Integrating Cancer and Aging at Pitt
皮特大学将癌症与衰老相结合
基本信息
- 批准号:6805788
- 负责人:
- 金额:$ 64.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Description) The goal of this proposal, titled "Integrating Cancer and Aging at Pitt", is to establish a standing Cancer and Aging Program within the University of Pittsburgh Cancer Institute. The core mission of the Cancer and Aging Program will be to develop and test interventions to improve health outcomes in older persons with cancer. In order to develop the Cancer and Aging Program, over the next five years, we will 1) implement a series of activities designed to reduce barriers and promote collaboration, 2) perform pilot translational research studies to better understand the immunobiology of cancer in elderly patients and apply insights to develop more effective treatment, 3) collect, develop, evaluate and disseminate aging-relevant measures of co-morbidity, functioning and cancer outcomes, and 4) develop and test promising medical, behavioral and social interventions for older people with cancer. We will build on institutional strengths to expand collaborative research in three main areas identified in the Aging and Cancer Workshop Report; 1) translational research on immunobiology of cancer and aging, 2) clinical trials of treatment efficacy and tolerance in the context of age related co-morbidity and 3) behavioral and social issues in older cancer patients. Since cancer care planning should depend not on chronological age, but on life expectancy, ability to tolerate treatment, and patient goals, we envision developing a spectrum of care strategies tailored to the individual health and functional status of the cancer patient aged 65 and over. In order to further identify barriers to collaborative research on aging and cancer, and to design strategies to overcome them, we plan a first year series of interactions with critical constituencies from academics and clinical practice at Pitt, with clinicians from the region, and with older cancer survivors and caregivers in the community. We see successful collaboration as dependent on our ability to accommodate and incorporate each potential contributor's perspective, experience and priorities. In order to sustain a feedback loop between our constituencies and our Program, we propose standing academic, clinical and community advisory groups. This proposal includes plans for: 1) a series of workshops and retreats designed to engage representatives from all of the relevant disciplines and constituencies, identify possible barriers to the success of the Program and implement strategies to overcome them, 2) seminars and conferences designed to promote innovative and collaborative research in cancer and aging, 3) a pilot research program to support initial projects considered to be of high scientific quality and of central relevance to the goals of the Program, 4) development of a new Measurement in Aging and Cancer Resource Core, 5) the inclusion of aging issues into relevant existing programs and shared resource facilities of the UPCI and 6) inclusion of cancer issues into major programs of the University of Pittsburgh Institute on Aging (UPIA).
描述:(申请人的描述)这项题为“匹兹堡大学癌症与老龄化整合”的提案的目标是在匹兹堡大学癌症研究所内建立一个常设癌症与老龄化项目。 癌症与老龄化计划的核心任务是开发和测试干预措施,以改善患有癌症的老年人的健康结果。 为了发展癌症与老龄化计划,在未来五年内,我们将 1) 实施一系列旨在减少障碍和促进合作的活动,2) 进行试点转化研究,以更好地了解老年患者癌症的免疫生物学并应用见解来开发更有效的治疗方法,3) 收集、开发、评估和传播与衰老相关的共病、功能和癌症结果的衡量标准,以及 4) 为患有癌症的老年人开发和测试有前景的医疗、行为和社会干预措施。 我们将利用机构优势,扩大老龄化与癌症研讨会报告中确定的三个主要领域的合作研究; 1) 癌症和衰老免疫生物学的转化研究,2) 年龄相关共病背景下治疗效果和耐受性的临床试验,3) 老年癌症患者的行为和社会问题。 由于癌症护理计划不应取决于实际年龄,而应取决于预期寿命、耐受治疗的能力和患者目标,因此我们设想制定一系列针对 65 岁及以上癌症患者的个人健康和功能状态的护理策略。 为了进一步确定衰老和癌症合作研究的障碍,并设计克服这些障碍的策略,我们计划在第一年与皮特大学学术界和临床实践的关键群体、来自该地区的临床医生以及老年人进行一系列互动。社区中的癌症幸存者和护理人员。 我们认为成功的合作取决于我们容纳和整合每个潜在贡献者的观点、经验和优先事项的能力。 为了维持我们的选区和我们的计划之间的反馈循环,我们建议常设学术、临床和社区咨询小组。 该提案包括以下计划:1) 一系列研讨会和务虚会,旨在吸引所有相关学科和选区的代表参与,确定该计划成功可能遇到的障碍,并实施克服这些障碍的策略,2) 研讨会和会议,旨在促进癌症和衰老领域的创新和合作研究,3)试点研究计划,以支持被认为具有高科学质量且与计划目标密切相关的初始项目,4)开发新的衰老和癌症测量资源核, 5) 将老龄化问题纳入 UPCI 的相关现有项目和共享资源设施,以及 6) 将癌症问题纳入匹兹堡大学老龄化研究所 (UPIA) 的主要项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD B HERBERMAN其他文献
RONALD B HERBERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD B HERBERMAN', 18)}}的其他基金
Development Of Center For Rapid Cancer Drug Discovery
癌症药物快速发现中心的发展
- 批准号:
6830570 - 财政年份:2004
- 资助金额:
$ 64.55万 - 项目类别:
相似国自然基金
周边与中央视觉拥挤效应的心理物理学与脑机制研究及临床应用
- 批准号:32371097
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MicroRNA-23a/HMGN2通过染色质重塑调控中性粒细胞抗细菌免疫的作用机制及其临床检测价值研究
- 批准号:82302630
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DDX3Y调控Wnt/β-catenin信号通路在肿瘤免疫治疗疗效中的机制和临床价值研究
- 批准号:82372331
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于先进深度学习模型的面向临床多模态乳腺癌诊断方法研究
- 批准号:62371312
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
The role of amphiregulin in mediating radiation cystitis in cancer survivors
双调蛋白在介导癌症幸存者放射性膀胱炎中的作用
- 批准号:
10636699 - 财政年份:2023
- 资助金额:
$ 64.55万 - 项目类别:
Roles of Glial Autophagy in Breast Cancer Brain Metastasis
胶质细胞自噬在乳腺癌脑转移中的作用
- 批准号:
10660141 - 财政年份:2023
- 资助金额:
$ 64.55万 - 项目类别:
Engineered hybrid aging model for disease progression
用于疾病进展的工程混合衰老模型
- 批准号:
10608767 - 财政年份:2023
- 资助金额:
$ 64.55万 - 项目类别:
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
糖化与祖先特异性肿瘤基质之间的因果关系
- 批准号:
10586185 - 财政年份:2023
- 资助金额:
$ 64.55万 - 项目类别:
Improving Patient-Centered Decision-Making for Stress Urinary Incontinence Treatment in Older Men
改善老年男性压力性尿失禁治疗中以患者为中心的决策
- 批准号:
10729838 - 财政年份:2023
- 资助金额:
$ 64.55万 - 项目类别: